Join this webinar to discover how adopting leading industry practices in consortium models can revolutionize your drug discovery efforts. We’ll showcase Curia Global’s innovative scaffold, template, and enumerated library design, which is industry-tested and highly acclaimed. Learn how our proven approach in complex chemistry has successfully produced 164,000 compounds for high-throughput screening (HTS), and how our cutting-edge design and synthetic expertise enable Curia to expand its compound library offerings.
Attendees will learn how to leverage these advancements to enhance their drug discovery processes, improve efficiency in identifying viable compounds, and access an extensive range of virtual and synthetically accessible compounds. Don’t miss this chance to learn how to accelerate your projects and achieve success.
Key Learning Objectives:
- Understand the distinction between Curia’s Virtual Library (CVL) and Compound Library Consortium (CLC).
- Hear how to increase efficiency in identifying viable compounds to speed drug discovery.
- Explore how to access and evaluate scaffolds, templates and enumerated compound libraries through CVL.
Who Should Attend:
- Medicinal chemists
- Computational chemists
- In vitro pharmacologists
- Directors of HTS
- Structural biologists